Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment

Author(s):
Weibel, D.; Sturkenboom, M.; Black, S.; Ridder, M. de; Dodd, C.; Bonhoeffer, J.; Vanrolleghem, A.; Maas, N. van der; Lammers, G.J.; Overeem, S.; Gentile, A.; Giglio, N.; Castellano, V.; Kwong, J.C.; Murray, B.J.; Cauch-Dudek, K.; Juhasz, D.; Campitelli, M.; Datta, A.N.; Kallweit, U.; Huang, W.T.; Huang, Y.S.; Hsu, C.Y.; Chen, H.C.; Giner-Soriano, M.; Morros, R.; Gaig, C.; Tio, E.; Perez-Vilar, S.; Diez-Domingo, J.; Puertas, F.J.; Svenson, L.W.; Mahmud, S.M.; Carleton, B.; Naus, M.; Arnheim-Dahlstrom, L.; Pedersen, L.; DeStefano, F.; Shimabukuro, T.T.
Published
2018
Publication type
Article / Letter to editor
NarcolepsyPandemic H1N1 influenzaAdjuvantAS03MF59
Date issued
2018-10-01
Language
English
Is part of
Vaccine (2018), Vol. 36, no. 41, p. 6202-6211
hdl
1887/77682
doi
10.1016/j.vaccine.2018.08.008